News

See the latest news about TARA, press releases, videos, and events. We're active in the drug discovery and cardiac toxicology communities, so keep an eye out for conferences we're attending.

Heart-on-a-Chip Mimics Drug Response Seen in Humans: In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery

NEW YORK, N.Y. (Newswire.com)— Researchers from TARA Biosystems, Inc. and GlaxoSmithKline (GSK) today published data demonstrating that TARA’s engineered heart-on-a-chip system replicated drug responses found in adult humans. The

READ MORE

TARA Secures Exclusive Worldwide License to Columbia University Intellectual Property relating to Engineered Human Cardiac Tissues

NEW YORK, N.Y. (Newswire.com)— TARA Biosystems, Inc. (TARA), a company offering physiologically relevant human “heart-on-a-chip” tissue models for cardiac risk assessment and drug discovery applications, today announced the execution of an exclusive worldwide license agreement with Columbia …

READ MORE

TARA Announces Issuance of US Patent for Biowire™ II Platform

New York, NY, (Newswire.com) - TARA Biosystems, Inc. (TARA), a company offering physiologically relevant human “heart-on-a-chip” tissue models for cardiac risk assessment and drug discovery applications, today announced that the United States Patent and Trademark Office (USPTO) has …

READ MORE

TARA presents at WuXi Healthcare Forum in Shanghai

TARA presents today at the WuXi Healthcare Forum in Shanghai.  The forum brings together 1000+ innovators, entrepreneurs, clinicians, and investors from around the world that are shaping the future of healthcare.

READ MORE

TARA Biosystems Biowire™ II Heart-on-a-Chip Platform Published in CELL

NEW YORK, (Newswire.com) TARA Biosystems, Inc., a company offering physiologically relevant human “heart-on-a-chip” tissue models for cardiac risk assessment and drug discovery applications, today announced the first peer-reviewed publication of its Biowire™ II platform by a team of …

READ MORE